Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data

Epidemiology

Volumn 26, Issue 5, 2015, Pages 653-660

  Van Sighem, Ard ^a   Nakagawa, Fumiyo ^b   De Angelis, Daniela ^c   Quinten, Chantal ^d   Bezemer, Daniela ^a   De Coul, Eline Op ^e   Egger, Matthias ^f   De Wolf, Frank ^g   Fraser, Christophe ^g   Phillips, Andrew ^b  

^a STICHTING HIV MONITORING   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f UNIVERSITY OF BERN   (Switzerland)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE SURVEILLANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MEN WHO HAVE SEX WITH MEN; NETHERLANDS; PREDICTION; PRIORITY JOURNAL; SECONDARY ANALYSIS; SENSITIVITY ANALYSIS; HEALTH SURVEY; HIV INFECTIONS; MALE HOMOSEXUALITY; PROCEDURES; THEORETICAL MODEL; TIME FACTOR;

HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MODELS, THEORETICAL; NETHERLANDS; PUBLIC HEALTH SURVEILLANCE; TIME FACTORS;

EID: 84940052743     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000324     Document Type: Article

References (42)

1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. UNAIDS/JC2502/1/E. Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013.
2. van Veen MG, Presanis AM, Conti S, et al. National estimate of HIV prevalence in the Netherlands: comparison and applicability of different estimation tools. AIDS. 2011;25:229-237.
3. Birrell PJ, Gill ON, Delpech VC, et al. HIV incidence in men who have sex with men in England and Wales 2001-10: a nationwide population study. Lancet Infect Dis. 2013;13:313-318.
4. Hamers FF, Phillips AN. Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med. 2008;9(Suppl 2):6-12.
5. Bezemer D, de Wolf F, Boerlijst MC, et al. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS. 2008;22:1071-1077.
6. Working Group on Estimation of HIV Prevalence in Europe. HIV in hiding: methods and data requirements for the estimation of the number of people living with undiagnosed HIV. AIDS. 2011;25:1017-1023.
7. Kretzschmar ME, Schim van der Loeff MF, Birrell PJ, De Angelis D, Coutinho RA. Prospects of elimination of HIV with test-and-treat strategy. Proc Natl Acad Sci USA. 2013;110:15538-15543.
8. Phillips AN, Cambiano V, Nakagawa F, et al. Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic. PLoS One. 2013;8:e55312.
9. Stover J, Brown T, Marston M. Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children. Sex Transm Infect. 2012;88(Suppl 2):i11-i16.
10. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2012. Stockholm, European Centre for Disease Prevention and Control, 2013.
11. Smith MK, Powers KA, Muessig KE, Miller WC, Cohen MS. HIV treatment as prevention: the utility and limitations of ecological observation. PLoS Med. 2012;9:e1001260.
12. Campsmith ML, Rhodes PH, Hall HI, Green TA . Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr. 2010;53:619-624.
13. Sweeting MJ, De Angelis D, Aalen OO. Bayesian back-calculation using a multi-state model with application to HIV. Stat Med. 2005;24:3991-4007.
14. Ndawinz JD, Costagliola D, Supervie V. New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: results for France. AIDS. 2011;25:1905-1913.
15. Becker NG, Lewis JJ, Li Z, McDonald A. Age-specific back-projection of HIV diagnosis data. Stat Med. 2003;22:2177-2190.
16. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:1-19.
17. Lodi S, Phillips A, Touloumi G, et al.; CASCADE Collaboration in EuroCoord. Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm: assessment of need following changes in treatment guidelines. Clin Infect Dis. 2011;53:817-825.
18. Cori A, Ayles H, Beyers N, et al.; HPTN 071 PopART Study Team. HPTN 071 (PopART ): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PLoS One. 2014;9:e84511.
19. Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollingsworth TD, Fraser C. 27 years of the HIV epidemic amongst men having sex with men in the Netherlands: an in depth mathematical model-based analysis. Epidemics. 2010;2:66-79.
20. Bochow M, Chiarotti F, Davies P, et al. Sexual behaviour of gay and bisexual men in eight European countries. AIDS Care. 1994;6:533-549.
21. Mikolajczak J, Hospers HJ, Kok G. Reasons for not taking an HIV-test among untested men who have sex with men: an Internet study. AIDS Behav. 2006;10:431-435.
22. Alioum A, Commenges D, Thiebaut R, Dabis F. A multistate approach for estimating the incidence of human immunodeficiency virus by using data from a prevalent cohort study. Appl Statist. 2005;54:739-752.
23. van Sighem A, Gras L, Kesselring A, Smit C, et al; on behalf of the Netherlands collaborative HIV treatment centres. Monitoring Report 2013. Human Immunodeficiency Virus (HIV) Infection in the Netherlands. Amsterdam, The Netherlands: Stichting HIV Monitoring, 2013.
24. Soetens LC, Koedijk FDH, van den Broek IVF, et al. Sexually transmitted infections, including HIV, in the Netherlands in 2012. RIVM report 150002003/2013. Bilthoven, The Netherlands: National Institute for Public Health and the Environment, Ministry of Health, Welfare and Sport, 2013.
25. Sanchez MA, Blower SM. Uncertainty and sensitivity analysis of the basic reproductive rate. Tuberculosis as an example. Am J Epidemiol. 1997;145:1127-1137.
26. van Sighem A, Vidondo B, Glass TR, et al.; Swiss HIV Cohort Study. Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study. PLoS One. 2012;7:e44819.
27. Phillips AN, Sabin C, Pillay D, Lundgren JD. HIV in the UK 1980-2006: reconstruction using a model of HIV infection and the effect of antiretroviral therapy. HIV Med. 2007;8:536-546.
28. CA SCADE (Concerted Action on SeroConversion to AIDS and Death in Europe) Collaboration. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet 2000; 355:1131-1137.
29. Lodi S, Phillips A, Touloumi G, et al.; CASCADE Collaboration. CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era. AIDS. 2010;24:2697-2704.
30. Natural History Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Factors associated with short-term changes in HIV viral load and CD4+ cell count in antiretroviral-naive individuals. AIDS 2014; 28:1351-1356.
31. Müller V, Maggiolo F, Suter F, et al. Increasing clinical virulence in two decades of the Italian HIV epidemic. PLoS Pathog. 2009;5:e1000454.
32. Gras L, Geskus RB, Jurriaans S, et al.; ATHENA National Observational Cohort. Has the rate of CD4 cell count decline before initiation of antiretroviral therapy changed over the course of the Dutch HIV epidemic among MSM? PLoS One. 2013;8:e64437.
33. Goubar A, Ades AE, De Angelis D, et al. Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data. J R Statist Soc A. 2008;171:541-567.
34. van Empelen P, van Berkel M, Roos E, Zuilhof W. Schorer Monitor 2011. Amsterdam, The Netherlands: Schorer; 2011.
35. Supervie V, Ndawinz JD, Lodi S, Costagliola D. The undiagnosed HIV epidemic in France and its implications for HIV screening strategies. AIDS. 2014;28:1797-1804.
36. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. 2014. Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed May 7, 2014.
37. Mocroft A, Lundgren JD, Sabin ML, et al.; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013;10:e1001510.
38. Gras L, Kesselring AM, Griffin JT, et al.; ATHENA , Netherlands National Observational Cohort Study. CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. J Acquir Immune Defic Syndr. 2007;45:183-192.
39. Jansen IA, Geskus RB, Davidovich U, et al. Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study. AIDS. 2011;25:493-501.
40. van Sighem A, Jansen I, Bezemer D, et al. Increasing sexual risk behaviour among Dutch men who have sex with men: mathematical models versus prospective cohort data. AIDS. 2012;26:1840-1843.
41. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39:446-453.
42. Theijman T, Geskus RB, Davidovich U, Coutinho RA, Prins M, Stolte IG. Less decrease in risk behaviour from pre-HIV to post-HIV seroconversion among MSM in the combination antiretroviral therapy era compared with the pre-combination antiretroviral therapy era. AIDS. 2012;26:489-495.